Probiotic Holdings Announces $9 Million USD in Financing Year to Date
Probiotic Holdings, LLC and its subsidiaries Proviera Biotech, LLC and SCD Probiotics announced closing an additional $6 million investment bringing the total to $9.3 million USD since January 2019. The funds will be used to support and expand Probiotic Holdings’ 44,000-square-foot fermentation manufacturing and research and development laboratories; strengthen its technology platform; and enable the continued global commercialization of its organic, bio-based biochemicals and microbial products.